Related Experiment Videos
Drug and nutrient interactions in elderly cardiac patients
1Division of Nutritional Sciences, Cornell University, Ithaca, NY 14853.
Drug-Nutrient Interactions
|January 1, 1988
Summary
Drug therapy in the elderly prevents and controls cardiovascular disease, including managing high cholesterol and hypertension. This approach aims to reduce risks of heart attack, stroke, and improve management of chronic heart conditions.
Area of Science:
- Geriatric medicine
- Cardiovascular pharmacology
- Public health
Background:
- Cardiovascular disease (CVD) is a leading cause of morbidity and mortality in the elderly.
- Effective management of CVD risk factors is crucial for improving health outcomes in older adults.
- Current therapeutic strategies focus on prevention, acute event management, and chronic disease control.
Purpose of the Study:
- To outline the role of drug therapy in the prevention and management of cardiovascular disease in the elderly.
- To highlight key cardiovascular conditions targeted by pharmacologic interventions.
- To emphasize the goal of reducing disability and improving quality of life for elderly patients with CVD.
Main Methods:
- Review of established pharmacologic approaches for cardiovascular disease prevention and treatment in geriatric populations.
- Identification of common cardiovascular disorders managed with medication.
- Analysis of therapeutic targets, including hypercholesterolemia, hypertension, and acute myocardial infarction.
Main Results:
- Drug therapy is essential for managing hypercholesterolemia, reducing myocardial infarction risk.
- Pharmacologic interventions are critical for treating acute myocardial infarction and preventing recurrence.
- Hypertension management through drugs lowers risks of hypertensive heart disease and stroke.
- Commonly treated conditions include congestive heart failure, arrhythmias, angina, and thromboses.
Conclusions:
- Pharmacologic interventions are central to cardiovascular disease prevention and management in the elderly.
- Comprehensive drug treatment strategies address primary prevention, acute events, and chronic condition management.
- The ultimate goal is to mitigate cardiovascular disease impact, reduce permanent disability, and enhance longevity in older adults.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...